COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News

Patient receiving supplemental oxygen therapy | Image Credit: Doodeez - stock.adobe.com
Medicare Competitive Bidding Program Cuts Spending Without Impacting COPD Outcomes

November 29th 2024

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or clinical outcomes among patients with chronic obstructive pulmonary disease (COPD).

COPD illustration | Image Credit: peterschreiber.media - stock.adobe.com
2025 GOLD Report: New Insights on COPD Risks, Management

November 27th 2024

Lonely patient | Image Credit: amazing studio - stock.adobe.com
Social Isolation Linked to Increased Mortality in Patients With COPD

November 26th 2024

Closeup of hand with cardiogram on red heart | Image Credit: Syda Productions - stock.adobe.com
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk

November 21st 2024

China animation | Image Credit: vegefox.com - stock.adobe.com
COPD Mortality Falls in China, Yet High Burden Persists in Underdeveloped Regions

November 12th 2024

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Continuing Medical Education
View All
December 3rd 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Understanding Clinical Considerations for Patients With Both COPD, Cardiovascular Disease
July 18th 2020

Understanding Clinical Considerations for Patients With Both COPD, Cardiovascular Disease

Rachel Lutz
A recent review discussed how to manage comorbid cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).
Researchers Explore Benefits of Using Composite End Points in COPD Trials
July 17th 2020

Researchers Explore Benefits of Using Composite End Points in COPD Trials

Rachel Lutz
Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.
Does Diet Have an Effect on COPD Prevalence and Incidence?
July 11th 2020

Does Diet Have an Effect on COPD Prevalence and Incidence?

Rachel Lutz
The focus on curbing COPD prevalence has largely focused on smoking cessation, but there are other factors, including diet, that can contribute to the risk of developing COPD.
Poor Neighborhoods Affect Individual Health Outcomes in Those With COPD, Study Says
July 5th 2020

Poor Neighborhoods Affect Individual Health Outcomes in Those With COPD, Study Says

AJMC Staff
Results showed that living in a disadvantaged neighborhood is associated with worse COPD-related individual-level outcomes.
How Can Lung Cancer Screening Improve Early Detection of COPD?
July 3rd 2020

How Can Lung Cancer Screening Improve Early Detection of COPD?

Matthew Gavidia
Lung cancer screening by low-dose computed tomography does not examine spirometry in eligible patients, but study findings published this week suggest that adding this feature could improve the high burden of undiagnosed chronic obstructive pulmonary disease (COPD) and emphysema.
Understanding Early Predictors of Mortality in COPD
July 1st 2020

Understanding Early Predictors of Mortality in COPD

Allison Inserro
The investigators conducted the study to understand more about the influence of each predictive factor of mortality in chronic obstructive pulmonary disease (COPD), as rates of death from the pulmonary disease have risen worldwide.
Triple Therapy at 2 Doses Appears to Reduce COPD Exacerbations, Study Says
June 24th 2020

Triple Therapy at 2 Doses Appears to Reduce COPD Exacerbations, Study Says

Allison Inserro
A trial of 2 doses of an inhaled glucocorticoid in a fixed-dose triple therapy for chronic obstructive pulmonary disease (COPD) appeared beneficial compared with 1 of 2 dual therapies.
Can Inhaled Corticosteroids Slow COPD Lung Function Decline?
June 20th 2020

Can Inhaled Corticosteroids Slow COPD Lung Function Decline?

Rachel Lutz
Inhaled corticosteroids for patients with chronic obstructive pulmonary disease (COPD) may curb lung function decline, according to new research.
COPD Is an Independent Risk Factor of Colorectal, Liver, Other Cancers
June 19th 2020

COPD Is an Independent Risk Factor of Colorectal, Liver, Other Cancers

Gianna Melillo
Regardless of smoking status, chronic obstructive pulmonary disease (COPD) is an independent risk factor for developing lung, colorectal, liver and other cancers in the Korean population, according to a study published in BMC Pulmonary Medicine.
Lung Development May Explain Who Is at Higher Risk for COPD
June 11th 2020

Lung Development May Explain Who Is at Higher Risk for COPD

Allison Inserro
Up to 30% of cases of dysanapsis, having a small airway-to-lung ratio, occur in people who have never smoked, while not having the condition could explain why some heavy smokers never develop chronic obstructive pulmonary disease (COPD).
Express Scripts Adds COPD, Asthma Treatments to National Formulary
June 7th 2020

Express Scripts Adds COPD, Asthma Treatments to National Formulary

AJMC Staff
The formulary covers over 22 million US lives.
Importance of Key COPD Research Comes From All Trial Phases, Authors Say
June 6th 2020

Importance of Key COPD Research Comes From All Trial Phases, Authors Say

Rachel Lutz
Relying on one type of study often doesn’t paint the full picture of drug safety, efficacy, and economic and therapeutic benefits across the short and long term, the authors of the study wrote.
Study Details Characteristics of Patients with COPD, Asthma
May 30th 2020

Study Details Characteristics of Patients with COPD, Asthma

Rachel Lutz
Danish investigators reviewed data of individuals prescribed inhaled corticosteroids (ICS) for chronic obstructive pulmonary disease (COPD) to compare characteristics of patients who have COPD alone with those who have COPD and concomitant asthma.
Cognitive Behavioral Therapy Shows Small Benefits for Patients With COPD
May 27th 2020

Cognitive Behavioral Therapy Shows Small Benefits for Patients With COPD

Rachel Lutz
Pulmonary rehabilitation can offer many of the same ideas to patients that cognitive behavioral therapy (CBT) can, even inadvertently, the study authors said.
Early Detection Programs May Help Offset Costs of COPD Exacerbations, Studies Find
May 21st 2020

Early Detection Programs May Help Offset Costs of COPD Exacerbations, Studies Find

Rachel Lutz
Exacerbations of patients with chronic obstructive pulmonary disorder (COPD) can be costly if they are frequent, and early detection programs for COPD may help offset these costs, according to research from 2 studies presented at the 2020 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) virtual conference.
Chronic Breathlessness in COPD Affects All Aspects of Life, Both Patients, Caregivers Say
May 15th 2020

Chronic Breathlessness in COPD Affects All Aspects of Life, Both Patients, Caregivers Say

Rachel Lutz
Chronic breathlessness not only affects patients with chronic obstructive pulmonary disease (COPD) but also their caregivers, who are mostly women, according to a recent review.
Pulmonary Rehabilitation for COPD Linked to Lower Risk of Death in FFS Medicare
May 12th 2020

Pulmonary Rehabilitation for COPD Linked to Lower Risk of Death in FFS Medicare

Allison Inserro
Although pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) is linked to better survival, a large study of fee-for-service (FFS) Medicare patients show it is underused, with less than 2% of those studied taking part in a 3-month program.
Patients With COPD Given Bronchoscopic Lung Reduction Have Longer Median Survival
May 7th 2020

Patients With COPD Given Bronchoscopic Lung Reduction Have Longer Median Survival

Rachel Lutz
The patients selected for bronchoscopic lung volume reduction were younger compared with those who were not, the investigators said.
Site Logo
May 6th 2020

COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis

Michael R. Bogart, PharmD Sari D. Hopson, PhD, MSPH Huai-Che Shih, PhD Richard H. Stanford, PharmD, MS Anna D. Coutinho, PhD, BPharm
Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.
Acute Care Use by Patients With COPD Affected by Income Level, Stress, Study Says
April 28th 2020

Acute Care Use by Patients With COPD Affected by Income Level, Stress, Study Says

Rachel Lutz
Compared with patients with low stress, patients with chronic obstructive pulmonary disease (COPD) and high stress had doubled odds of using acute care services, a new study found.
High-Flow Nasal Therapy Can Cut Hospital Readmissions for COPD Acute Exacerbations
April 25th 2020

High-Flow Nasal Therapy Can Cut Hospital Readmissions for COPD Acute Exacerbations

Rachel Lutz
High-flow nasal therapy (HFNT), often used for stable patients, can reduce hospital readmission for acute exacerbations for chronic obstructive pulmonary disease (COPD).
COPD Not An Independent Risk Factor for Metabolic Disorders, Study Says
April 24th 2020

COPD Not An Independent Risk Factor for Metabolic Disorders, Study Says

Rachel Lutz
Chronic obstructive pulmonary disease (COPD) is not an independent risk factor for metabolic disorders, according to a recent report.
Patients With COPD, Acute Kidney Injury at Risk for Hospital Readmission, Study Says
April 12th 2020

Patients With COPD, Acute Kidney Injury at Risk for Hospital Readmission, Study Says

Rachel Lutz
Prevention of acute kidney injury should be top of mind when discharging patients with chronic obstructive pulmonary disease (COPD) from the hospital, according to a recent study.
Analyzing Changes in Frailty Among Patients With COPD
April 11th 2020

Analyzing Changes in Frailty Among Patients With COPD

Rachel Lutz
Over a 2-year study period, some patients with chronic obstructive pulmonary disease (COPD) were able to reverse or improve their frailty status, investigators found. The condition is present in close to one-third of patients with COPD.
Patients With COPD and No Smoking History Face Greater Risk of Lung Cancer, Study Says
April 3rd 2020

Patients With COPD and No Smoking History Face Greater Risk of Lung Cancer, Study Says

Allison Inserro
A large-scale study reports that patients with chronic obstructive pulmonary disease (COPD)—even if they never smoked—have a 2.6 times greater incidence of developing lung cancer compared with those who had neither COPD or a history of smoking.
Site Logo
April 2nd 2020

Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD

Yong Li, PhD Jonathan Lim, MSc Stephen Stemkowski, PhD Shuchita Kaila, PhD Andrew Renda, MD Asif Shaikh, MD
Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.
Site Logo
March 26th 2020

Practical Guidance to Improving COPD Management

Thomas C. Corbridge, MD, FCCP
Thomas C. Corbridge, MD, FCCP, is a GSK medical expert and an emeritus physician and adjunct professor of medicine at Northwestern University, Feinberg School of Medicine in Chicago, Illinois. Dr. Corbridge received his medical degree from the University of Chicago Pritzker School of Medicine and has been in practice for over 30 years. Dr. Corbridge specializes in pulmonary and critical care medicine and is experienced in asthma, chronic obstructive pulmonary disease and general pulmonology.
New Tool Uses Data to Predict Which Patients Have Higher Risk for Increased COPD Exacerbations
March 23rd 2020

New Tool Uses Data to Predict Which Patients Have Higher Risk for Increased COPD Exacerbations

Rachel Lutz
This study examined risk of exacerbation using a new predictive tool called COPD treatment ratio.
BODE Index, Comorbidities Valuable for Predicting COPD Healthcare Resource Utilization
March 21st 2020

BODE Index, Comorbidities Valuable for Predicting COPD Healthcare Resource Utilization

Alison Rodriguez
Chronic obstructive pulmonary disease (COPD) may incur huge medical expenses, resulting in a heavy socioeconomic burden. A recent study sought to predict the level of healthcare utilization resources.
What We're Reading: Amazon Shipments; New COPD Treatment; High-Profile Mergers on Hold
March 18th 2020

What We're Reading: Amazon Shipments; New COPD Treatment; High-Profile Mergers on Hold

AJMC Staff
Amazon has decided to suspend nonessential item shipments; study results show patients with chronic obstructive pulmonary disease (COPD) benefited from a fluticasone furoate/umeclidinium/vilanterol combination inhaler; disruptions from the coronavirus now extend to proposed mergers among industry giants.
<1
...
8910111213141516
...
25>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo